Detalhe da pesquisa
1.
ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.
Blood Cells Mol Dis
; 48(2): 132-6, 2012 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22134106
2.
Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
Hematology
; 20(3): 137-42, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25056761
3.
ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib.
Oncol Lett
; 7(4): 1313-1319, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24660038
4.
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia.
Med Oncol
; 31(3): 851, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24469953
5.
Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients
Hematology
; 20(3): 137-142, 2015.
Artigo
Inglês
| SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1063277
6.
Estudo da expressão dos genes ABCB1 e SLC22A1 e sua relação com marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica / Study of the expression of SLC22A1 and ABCB1 genes and their relationship with markers of response to imatinib mesylate in patients with chronic myeloid leukemia
São Paulo; s.n; s.n; 2014. 167 p. tab, graf, ilus.
Tese
Português
| LILACS | ID: biblio-836925